Price $2.59 |
Market Cap
37.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
0.97
|
P/S
0.91
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
5.8
|
Op. Cash Flow
6.8K
|
FCF
0.4
|
|
Op. Margin
-18.90%
|
Net Margin
-16.90%
|
ROE
-17.20%
|
ROI
-13.30%
|
|
ROA
-7.70%
|
EPS Growth
-
|
Current Ratio
2.4
|
Debt/Equity
35.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Mersana Therapeutics Inc (MRSN) | $6.64 | - | - | 687.4M | Strong Buy |
| IM Cannabis Corp (IMCC) | $1.25 | - | - | 14M | Strong Buy |
| Interpace Biosciences Inc (IDXG) | $1.08 | - | - | 4.3M | Strong Buy |
| Societal CDMO Inc (SCTL) | $1.50 | - | - | 116.6M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $3.09 | - | - | 127.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
